Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
September 26, 2015
Intramyocellular Lipid and Impaired Myofiber Contraction in Normal Weight and Obese Older Adults
Seung J Choi, D Clark Files, Tan Zhang, et al.
Journal of the Neurological Sciences
|
August 22, 2025
Reduction in oral glucocorticoid use after efgartigimod initiation in clinical practice among patients with generalized myasthenia gravis
Neelam Goyal, Cynthia Qi, John Stone, et al.
Scientific Reports
|
March 8, 2017
Preclinical evaluation of multi antigenic HCV DNA vaccine for the prevention of Hepatitis C virus infection
Hyojin Lee, Moonsup Jeong, Jooyeon Oh, et al.
JCI Insight
|
August 26, 2020
Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitis
Kasia Owczarczyk, Matthew D Cascino, Cecile Holweg, et al.
The Journal of Rheumatology
|
December 7, 2005
Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7
Peter A Merkel, Philip Seo, Peter Aries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2010
Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval
Peter C Fong, Timothy A Yap, David S Boss, et al.
JCI Insight
|
December 8, 2022
A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren's syndrome
Xavier Mariette, Francesca Barone, Chiara Baldini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2025
AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid Tumors
Lillian L Siu, Sophie Postel-Vinay, Rafael Villanueva-Vázquez, et al.
BMC Cancer
|
November 19, 2021
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocol
Stephan Ursprung, Helen Mossop, Ferdia A Gallagher, et al.
Clinical Pharmacology and Therapeutics
|
October 28, 2020
Depletion of LAG-3<sup>+</sup> T Cells Translated to Pharmacology and Improvement in Psoriasis Disease Activity: A Phase I Randomized Study of mAb GSK2831781
Joanne Ellis, Daniel J B Marks, Naren Srinivasan, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
September 26, 2015
Intramyocellular Lipid and Impaired Myofiber Contraction in Normal Weight and Obese Older Adults
Seung J Choi, D Clark Files, Tan Zhang, et al.
Journal of the Neurological Sciences
|
August 22, 2025
Reduction in oral glucocorticoid use after efgartigimod initiation in clinical practice among patients with generalized myasthenia gravis
Neelam Goyal, Cynthia Qi, John Stone, et al.
Scientific Reports
|
March 8, 2017
Preclinical evaluation of multi antigenic HCV DNA vaccine for the prevention of Hepatitis C virus infection
Hyojin Lee, Moonsup Jeong, Jooyeon Oh, et al.
JCI Insight
|
August 26, 2020
Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitis
Kasia Owczarczyk, Matthew D Cascino, Cecile Holweg, et al.
The Journal of Rheumatology
|
December 7, 2005
Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7
Peter A Merkel, Philip Seo, Peter Aries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2010
Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval
Peter C Fong, Timothy A Yap, David S Boss, et al.
JCI Insight
|
December 8, 2022
A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren's syndrome
Xavier Mariette, Francesca Barone, Chiara Baldini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2025
AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid Tumors
Lillian L Siu, Sophie Postel-Vinay, Rafael Villanueva-Vázquez, et al.
BMC Cancer
|
November 19, 2021
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocol
Stephan Ursprung, Helen Mossop, Ferdia A Gallagher, et al.
Clinical Pharmacology and Therapeutics
|
October 28, 2020
Depletion of LAG-3<sup>+</sup> T Cells Translated to Pharmacology and Improvement in Psoriasis Disease Activity: A Phase I Randomized Study of mAb GSK2831781
Joanne Ellis, Daniel J B Marks, Naren Srinivasan, et al.
Page
of 5